Note sull'episodio

When an FDA panel held her company’s future in the balance, UroGen Pharma CEO Liz Barrett refused to fold, even with the odds stacked, a plunging stock, and one vote deciding it all.

PODCAST TEAM

Producer and Director: Devon Leaver

Editor: Dominique Guerra

Production Coordinator: YingYu Lin

Production Support: Annabelle Chan

Story Consultants: Partner & Research Analyst Tony Nguyen, and Chief Corporate Finance Officer, Chris Seiter.

Featuring: Liz Barrett, President & CEO of UroGen Pharma, moderated by Stephanie A. Sirota, Partner and Chief Business Officer at RTW Investments, LP.

FOLLOW US

Love our podcast? Follow us on LinkedIn at

 ...  Leggi dettagli
Parole chiave
life scienceshealthcare investingbiotechhealthcanceroncology
Dove è stato create l'episodio
State
New York, USA